Cefixime 200mg + Ofloxacin 200mg

Jestycef-O 200 Tablet is a broad-spectrum antibacterial formulation designed to provide effective coverage against a wide range of Gram-positive and Gram-negative microorganisms. This combination brings together two well-established antimicrobial agents with complementary mechanisms of action, offering enhanced therapeutic strength in the management of bacterial infections.

Cefixime, a third-generation cephalosporin, works by inhibiting bacterial cell-wall synthesis, resulting in the weakening and eventual destruction of susceptible bacteria. It offers strong stability against many beta-lactamases, helping maintain effectiveness in certain resistant strains. Ofloxacin, a fluoroquinolone, targets bacterial DNA gyrase and topoisomerase IV, key enzymes necessary for DNA replication, repair, and transcription. Together, they create a synergistic effect that helps broaden antimicrobial coverage.

This combination is commonly used in clinical practice for infections involving the respiratory tract, urinary tract, gastrointestinal system, and certain soft-tissue structures, as guided by a healthcare professional. The dual-action approach supports faster control of bacterial load and may help reduce the risk of treatment failure in mixed infections or cases where single-agent therapy may be insufficient.

The tablets are formulated for convenient oral administration, with consistent pharmacokinetic profiles supporting reliable absorption and therapeutic activity. They are typically recommended when a physician determines that combination therapy is beneficial based on the patient’s clinical condition, local antimicrobial susceptibility patterns, and medical history.

As with all prescription antimicrobial medications, use should be based on professional medical advice. Completion of the full treatment course, even if symptoms improve, helps minimize the risk of relapse and microbial resistance.